Catalyst
Slingshot members are tracking this event:
Takeda's (TKPYY) NINLARO Granted Conditional Approval by European Commission to Treat Multiple Myeloma
- Source Link:
- https://www.takeda.com/news/2016/20161124_7626.html
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| TKPYY |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 24, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Ninlaro, Conditional Approval, European Commission, Multiple Myeloma
